|
GRCE Grace Therapeutics, Inc 1444192 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-7,793,000.00 |
| Balance Sheet |
|
Current Assets
|
$17,380,000.00 |
|
Assets
|
$66,654,000.00 |
|
Current Liabilities
|
$2,146,000.00 |
|
Liabilities
|
$2,758,000.00 |
|
Equity
|
$63,896,000.00 |
|
Shares Out
|
15474026.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-8,869,000.00 |
| Market Analysis |
Market Cap
|
$32,031,233.82 |
|
Price
|
$2.10 |
|
BVPS
|
4.13 |
|
PB
|
0.50 |
|
EPS
|
-0.47 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:41 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:41 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GRCE documents filed with the SEC.
GRCE Filings
Clear
